文献速递临床试验与 GCP

推拿联合药膏治疗卒中后抑郁的随机对照试验方案

The efficacy of Tuina with herbal ointment for patients with post-stroke depression: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-07-28

本研究为一项随机对照试验方案,计划纳入84例卒中后抑郁患者,1:1随机分为推拿联合药膏组和药膏对照组,所有患者均接受文拉法辛75mg每日一次基础治疗。干预每周5次、持续2周,主要结局为汉密尔顿抑郁量表,随访至3个月,以评估推拿联合药膏的疗效与安全性。

要点

  • 推拿联合药膏可能改善卒中后抑郁患者精神状态,尚待本试验验证。
  • 所有患者均接受文拉法辛75mg每日一次作为基础抗抑郁治疗。
  • 主要结局为HAMD,次要结局包括TMS、SF-36和TESS。

核心结论

  • 本试验旨在观察和验证推拿联合药膏治疗卒中后抑郁的疗效,并为其作用机制研究奠定基础。

研究设计与样本

  • 采用平行随机对照试验设计,计划纳入84例合格参与者,按1:1比例随机分配至推拿联合药膏组或药膏对照组。
  • 所有参与者均接受常规抗抑郁药文拉法辛治疗(75 mg QD),两组分别叠加不同干预,每周5次、持续2周。
  • 结局在基线、干预结束时(2周)以及随访1个月和3个月时评估,采用重复测量方差分析,显著性水平为5%。
  • 所有结局由对治疗分配设盲的研究者评估和分析,每次访视监测不良事件以评估安全性。

关键数值与推荐

  • 主要结局为汉密尔顿抑郁量表(HAMD)。
  • 次要结局包括经颅磁刺激(TMS)、36项简短健康调查(SF-36)和治疗 emergent 症状量表(TESS)。

临床怎么用

  • 若试验证实有效,推拿联合药膏可作为卒中后抑郁的辅助治疗选择,但需等待结果发表。

局限性

  • 本文为研究方案,尚无疗效结果;样本量84例,随访至3个月,长期疗效未知。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Post-stroke depression (PSD) is a common complication after stroke which hinders functional recovery and return to social participation of stroke patients. Efficacy of conventional drug therapies for patients with PSD is still uncertain. Therefore, many patients prefer to use complementary and alternative therapies for PSD. Tuina (traditional Chinese manual manipulation) with herbal ointment is an integration of manual therapy, and ointment is an important part of traditional Chinese medicine (TCM) therapy. Preliminary experiments have shown that the Tuina with herbal ointment can improve the mental state of patients with PSD. The purpose of this study is to observe and verify the efficacy of Tuina combined with herbal ointment for patients with post-stroke depression, and to lay a foundation for further research on its mechanism of action. METHODS/DESIGN: In this study, a randomized controlled trial will be conducted in parallel, including two intervention groups: Tuina with herbal ointment group and herbal ointment for control group. A total of 84 eligible participants will be randomly assigned to the groups in a 1:1 ratio. All participants will receive conventional antidepressant venlafaxine treatment (75 mg QD), on which they received two different interventions. The interventions for both groups will be carried out 5 times each week for a period of 2 weeks. The primary outcome will be the Hamilton Rating Scale for Depression (HAMD). Secondary outcomes will include transcranial magnetic stimulation (TMS), as well as 36-item Short-Form Health Survey (SF-36) and Treatment Emergent Symptom Scale (TESS). They will be assessed at the baseline, at the end of the intervention (2 weeks), and during the 1 month and 3 months of follow-up by repeated measures analysis of variance. The significance level is 5%. Adverse events will be monitored at each visit to assess safety. All outcomes will be assessed and analyzed by researchers blinded to the treatment allocation. The purpose of this study will focus on observing the efficacy of Tuina with herbal ointment for patients with post-stroke depression, and to explore further the mechanisms of its effects. DISCUSSION: This study may evaluate clinical application value and safety of Tuina with herbal ointment in PSD patients, which can provide basis for clinical research and mechanism exploration of PSD. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2000033887 . Registered on 15 June 2020. DISSEMINATION: The results will be published in peer-reviewed journals and disseminated through the study's website and conferences.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Tao J, Kong L, Fang M, et al. The efficacy of Tuina with herbal ointment for patients with post-stroke depression: study protocol for a randomized controlled trial. Trials. 2021. PMID: 34321056. doi:10.1186/s13063-021-05469-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。